Novo-Backed Respiratory Drugmaker Avalyn Pharma Files for US IPO
Avalyn Pharma Inc., a biopharma company developing inhaled treatments for respiratory diseases, filed for a US initial public offering.
Original Source
Read the full article at Bloomberg →KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.